Baird Financial Group
GRNA

Baird Financial Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Baird Financial Group’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-965,080
Closed -$417K – 1775
2023
Q1 		$417K Sell
965,080
-588,390
-38% -$452K ﹤0.01% 1382
2022
Q4 		$1.83M Sell
1,553,470
-1,303,225
-46% -$2.12M ﹤0.01% 901
2022
Q3 		$6.63M Buy
+2,856,695
New +$7.48M 0.02% 504

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

Baird Financial Group's GRNA Position: Q2 2023 in Review

Baird Financial Group sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q2 2023, closing a stake of 965,080 shares — an estimated $417K sold.

Baird Financial Group first reported a position in GRNA in Q3 2022 and held it in 3 quarters. The position peaked at $6.63M in Q3 2022. 48 funds tracked by Wall St. Rank hold GRNA as of Q2 2023.

  • Baird Financial Group reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q2 2023 after selling out during the quarter.
  • Baird Financial Group sold 965,080 GreenLight Biosciences Holdings, PBC Common Stock shares in Q2 2023, an estimated $417K.
  • Baird Financial Group first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q3 2022 and held it in 3 quarters.
  • Baird Financial Group's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $6.63M in Q3 2022.
  • 48 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q2 2023.

Based on Baird Financial Group's 13F filing for Q2 2023, filed 11 Aug 2023.